ISPOR 2020: how may we enable faster access to multi-indication orphan products? Rare disease and orphan drug abstract highlights

Written by The Evidence Base

What research was due to have been presented at the 2020 ISPOR Annual Meeting (18–20 May)? We summarize our abstract highlights, available to view online, focusing on rare diseases and orphan drugs. Due to the COVID-19 outbreak, the 2020 ISPOR Annual Meeting (18—20 May) has been redesigned to bring you nearly 60 hours of virtual health economics and outcomes research content! The Evidence Base® is proud to be partnering with ISPOR to bring you coverage of the event, including plenary summaries, exclusive interviews with speakers and more! Check out our dedicated channel to view the latest coverage>> Interested in partnering...

To view the full article, please register now for access

It's completely free